{"version":"1.0","type":"link","title":"Perioperative Enfortumab Vedotin and Pembrolizumab in Bladder Cancer.","author_name":"Vulsteke C 외","author_url":"https://prs-insight.online/author/Vulsteke%20C","provider_name":"PRSinsight","provider_url":"https://prs-insight.online","thumbnail_url":"https://prs-insight.online/og/paper/167141","thumbnail_width":1200,"thumbnail_height":630}